Different kinetics of WT1 and PML-RARalpha gene expression levels during remission induction therapy with all-trans retinoic acid alone in acute promyelocytic leukemia.
Tamaki
Hiroya
H
Yamagami
Tamotsu
T
Kawakami
Manabu
M
Kim
Eui Ho
EH
Mishima
Machiko
M
Kawase
Ichiro
I
Soma
Toshihiro
T
Ogawa
Hiroyasu
H
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D015973:Gene Expression Regulation, Leukemic / Q000187:drug effects; D018922:HL-60 Cells; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D015514:Oncogene Proteins, Fusion / Q000096:biosynthesis*; D012074:Remission Induction; D013997:Time Factors; D014212:Tretinoin / Q000008:administration & dosage*; D025721:WT1 Proteins / Q000096:biosynthesis*
D000970:Antineoplastic Agents; D015514:Oncogene Proteins, Fusion; D025721:WT1 Proteins; C093476:promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein; D014212:Tretinoin